Clinical Trial Update: Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating hydroxychloroquine for SARS-CoV-2 pneumonia/COVID-19 has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2 Pneumonia

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Kootenai Health | Conditions: SARS-CoV-2 Pneumonia, COVID-19 | Phase 4 | Status: WITHDRAWN